HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elfatih Elzein Selected Research

N- ((1S,trans)- 2- hydroxycyclopentyl)adenosine

12/2008A1 adenosine receptor agonists and their potential therapeutic applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elfatih Elzein Research Topics

Disease

2Insulin Resistance
01/2009 - 12/2008
1Long Qt Syndrome 3
11/2016
1Ischemia
10/2016
1Type 2 Diabetes Mellitus (MODY)
12/2008
1Atrioventricular Block
07/2004
1Stable Angina
02/2004

Drug/Important Bio-Agent (IBA)

22- (6- ((2- hydroxycyclopentyl)amino)purin- 9- yl)- 5- ((2- fluorophenylthio)methyl)oxolane- 3,4- diolIBA
01/2009 - 12/2008
1eleclazineIBA
11/2016
1SodiumIBA
10/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2016
1Insulin (Novolin)FDA Link
12/2008
1N- ((1S,trans)- 2- hydroxycyclopentyl)adenosineIBA
12/2008
1tecadenosonIBA
12/2008
1selodenosonIBA
12/2008
1capadenosonIBA
12/2008
1Pharmaceutical PreparationsIBA
12/2008
1Purinergic P1 Receptors (Adenosine Receptor)IBA
07/2004
1Fatty Acids (Saturated Fatty Acids)IBA
02/2004

Therapy/Procedure

2Therapeutics
01/2009 - 12/2008
1Pain Management
12/2008